Natesto Effects on Reproductive Hormones and Semen Parameters: Results from an Ongoing Single-center, Investigator-initiated Phase IV Clinical Trial

Overview of attention for article published in European Urology Focus , September 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#35 of 1,675)
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 6 news outlets
twitter: 8 X users

reddit: 1 Redditor
f1000: 1 research highlight platform

Readers on

mendeley: 10 Mendeley

So far, Altmetric has seen 7 news stories from 6 outlets.

Aytu BioScience Announces Publication of Manuscript Summarizing Results from the Ongoing Natesto(R) Spermatogenesis Study - Press Release

Digital Journal, 17 Sep 2018

Sperm Concentration, Motility, and Total Motile Sperm Count Remain Within Normal Ranges in Hypogonadal Men Taking Natesto…

News story from Finanz Nachrichten on Monday 17 September 2018

Finanz Nachrichten, 17 Sep 2018

Acerus Announces Publication of Manuscript Reporting Early Data from Partner-Sponsored Natesto® Spermatogenesis Study

BioSpace, 17 Sep 2018

Sept. 17, 2018 11:00 UTC -- Early Data Suggests Sperm Concentration, Motility, and Total Motile Sperm Count Remain Within…

Acerus Announces Publication of Manuscript Reporting Early Data from Partner-Sponsored Natesto® Spermatogenesis Study - Press Release

Digital Journal, 17 Sep 2018

TORONTO--(Business Wire)--Acerus Pharmaceuticals Corporation (TSX: ASP) (“Acerus” or the “Company”) today announced the…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 3 additional news stories.